Thu-07-03-2019, 21:27 PM
(Thu-07-03-2019, 20:20 PM)jiml Wrote: That's an interesting one as it has gone for a totally different target IL36R to other drugs available, so will be good to see the long term effectiveness on a larger sample of sufferers ....but definitely one to watch
Yes it is a good move. Pustular psoriasis is not so common, but it's one of the worse.
(Thu-07-03-2019, 20:59 PM)artemie Wrote: sure is interesting. normally this kind of news comes with noted side effects, like... upper respatory infections and such (Artemie knows about those =/ .... but this one doens't. Does anybody know if there are any?
Sorry that is all there is available at the moment. It's early days, so we will have to wait and see.